Absolutely. That's a really valid point.
What's interesting is that as treatments are getting better and survivors are living longer, the need for more therapies and more therapeutics to ensure there's a good quality of life really is critical. There are certain drugs now that are beneficial in preventing recurrences, but the studies on them are still limited by the pool samples.